DONATE

Giuseppe Battaglia

Group leader

The IBEC and West China Hospital hold their third joint conference on precision medicine in Barcelona

Barcelona hosted the third IBEC-WCH Precision Medicine Conference this week, an event that further strengthened the strategic alliance between the Institute for Bioengineering of Catalonia (IBEC) and the West China Hospital of Sichuan University (WCHSU). The Chinese delegation visited Spain from 26 to 29 November, taking part in a busy schedule of scientific and institutional activities and exchanges between the two centres.

IBEC research takes third place in the 2025 Vanguardia de la Ciencia Awards

A study led by IBEC has won the 3rd Vanguardia de la Ciencia 2025 Prize. The research, led by Samuel Sánchez Ordoñez and with Meritxell Serra-Casablanca as lead author, proposes an innovative bladder cancer therapy based on nanorobots loaded with radiopharmaceuticals. These nanorobots are capable of moving around the bladder using urine as a source of energy.

IBEC, one of the centres selected by the Pasqual Maragall Foundation for its research grants

Amaya Hernández-Vega, a senior researcher at IBEC, will lead one of the two projects selected in the 2024 call for proposals from the Pasqual Maragall Research Programme, which is dedicated to funding research into Alzheimer’s disease and other neurodegenerative conditions. IBEC also celebrates the participation of Jordi Duran, an associate researcher from the Molecular and Cellular Neurobiotechnology group, who will collaborate on the second selected project.

Scientists reverse Alzheimer’s in mice using nanoparticles

An international team co-led by the Institute for Bioengineering of Catalonia (IBEC) and the West China Hospital Sichuan University (WCHSU) was able to reverse Alzheimer’s in mice after only 3 injections with nanoparticles. The innovative approach to treating the disease focuses on restoring the normal function of the vasculature, rather than acting on neurons or other brain cells, as has usually been done until now. This achievement, published in the Signal Transduction and Targeted Therapy Journal, is a promising step towards an effective treatment for Alzheimer’s disease.

Cookies
Cookie Consent The IBEC website uses cookies and similar technologies to ensure the basic functionality of the site and for statistical and optimisation purposes. It also uses cookies to display content such as YouTube videos that use marketing cookies. This last category consists of tracking cookies: these make it possible for your online behaviour to be tracked. You consent to this by clicking on Accept. Also read our Privacy statement. Read our cookie policy
Settings Accept all
Cookies
Choose what kind of cookies to accept. Your choice will be saved for one year. Read our cookie policy
Save Accept all